{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T13:01:52Z","timestamp":1786626112130,"version":"build-2736575974"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T00:00:00Z","timestamp":1767398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T00:00:00Z","timestamp":1769990400000},"content-version":"vor","delay-in-days":30,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Natural Science Basic Research Program of Shaanxi","award":["2025JC-YBMS-211"],"award-info":[{"award-number":["2025JC-YBMS-211"]}]},{"DOI":"10.13039\/501100013254","name":"National College Students Innovation and Entrepreneurship Training Program","doi-asserted-by":"publisher","award":["202410699019, S202410699386 and S202310699317"],"award-info":[{"award-number":["202410699019, S202410699386 and S202310699317"]}],"id":[{"id":"10.13039\/501100013254","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013254","name":"National College Students Innovation and Entrepreneurship Training Program","doi-asserted-by":"publisher","award":["202410699019, S202410699386 and S202310699317"],"award-info":[{"award-number":["202410699019, S202410699386 and S202310699317"]}],"id":[{"id":"10.13039\/501100013254","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013254","name":"National College Students Innovation and Entrepreneurship Training Program","doi-asserted-by":"publisher","award":["202410699019, S202410699386 and S202310699317"],"award-info":[{"award-number":["202410699019, S202410699386 and S202310699317"]}],"id":[{"id":"10.13039\/501100013254","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Henan Province Middle-aged and Young Health Science and Technology Innovation Outstanding Youth Talent Training Project","award":["YXKC2021025"],"award-info":[{"award-number":["YXKC2021025"]}]},{"name":"2023 National Health Commission Scientific Research Fund-Henan Medical Science and Technology Research Plan Provincial and ministerial co-construction project","award":["SBGJ202302016"],"award-info":[{"award-number":["SBGJ202302016"]}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["D5000240285"],"award-info":[{"award-number":["D5000240285"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Commun Signal"],"DOI":"10.1186\/s12964-025-02619-9","type":"journal-article","created":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T08:14:43Z","timestamp":1767428083000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["PD\u2011L1 deficient exosomes derived from lung cancer cell line enhances NK cell\u2011mediated anti\u2011tumor immunity against lung cancer"],"prefix":"10.1186","volume":"24","author":[{"given":"Qi","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juanping","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wuli","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Shu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutong","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zijie","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Huyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,3]]},"reference":[{"issue":"5","key":"2619_CR1","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1038\/nri.2016.34","volume":"16","author":"NK Bjorkstrom","year":"2016","unstructured":"Bjorkstrom NK, Ljunggren HG, Michaelsson J. Emerging insights into natural killer cells in human peripheral tissues. Nat Rev Immunol. 2016;16(5):310\u201320.","journal-title":"Nat Rev Immunol"},{"issue":"5","key":"2619_CR2","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/ni1582","volume":"9","author":"E Vivier","year":"2008","unstructured":"Vivier E, et al. Functions of natural killer cells. Nat Immunol. 2008;9(5):503\u201310.","journal-title":"Nat Immunol"},{"key":"2619_CR3","doi-asserted-by":"crossref","unstructured":"Bjorgen JC, et al. NK cell subsets and dysfunction during viral infection: a new avenue for therapeutics? Front Immunol. 2023;14:1267774.","DOI":"10.3389\/fimmu.2023.1267774"},{"key":"2619_CR4","doi-asserted-by":"crossref","unstructured":"Clottu AS, et al. Innate lymphoid cells in autoimmune diseases. Front Immunol. 2022;12:789788.","DOI":"10.3389\/fimmu.2021.789788"},{"issue":"4","key":"2619_CR5","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1182\/bloodadvances.2024014592","volume":"9","author":"V Kuznetsova","year":"2025","unstructured":"Kuznetsova V, et al. Chronic inflammation deters natural killer cell fitness and cytotoxicity in myeloid leukemia. Blood Adv. 2025;9(4):759\u201373.","journal-title":"Blood Adv"},{"issue":"1","key":"2619_CR6","doi-asserted-by":"publisher","first-page":"2376410","DOI":"10.1080\/15384047.2024.2376410","volume":"25","author":"Y Qu","year":"2024","unstructured":"Qu Y, et al. Natural killer cell memory: challenges and opportunities for cancer immunotherapy. Cancer Biol Ther. 2024;25(1):2376410.","journal-title":"Cancer Biol Ther"},{"issue":"1","key":"2619_CR7","doi-asserted-by":"publisher","first-page":"100930","DOI":"10.1016\/j.tranon.2020.100930","volume":"14","author":"S Nersesian","year":"2021","unstructured":"Nersesian S, et al. NK cell infiltration is associated with improved overall survival in solid cancers: a systematic review and meta-analysis. Transl Oncol. 2021;14(1):100930.","journal-title":"Transl Oncol"},{"issue":"12","key":"2619_CR8","doi-asserted-by":"publisher","first-page":"2340","DOI":"10.1002\/ajh.27471","volume":"99","author":"R Dulery","year":"2024","unstructured":"Dulery R, et al. Haploidentical hematopoietic cell transplantation as a platform for natural killer cell immunotherapy. Am J Hematol. 2024;99(12):2340\u201350.","journal-title":"Am J Hematol"},{"issue":"1","key":"2619_CR9","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1080\/14712598.2020.1688298","volume":"20","author":"AG Pockley","year":"2020","unstructured":"Pockley AG, Vaupel P, Multhoff G. NK cell-based therapeutics for lung cancer. Expert Opin Biol Ther. 2020;20(1):23\u201333.","journal-title":"Expert Opin Biol Ther"},{"issue":"10","key":"2619_CR10","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1038\/s41423-024-01207-0","volume":"21","author":"L Peng","year":"2024","unstructured":"Peng L, et al. CAR-T and CAR-NK as cellular cancer immunotherapy for solid tumors. Cell Mol Immunol. 2024;21(10):1089\u2013108.","journal-title":"Cell Mol Immunol"},{"issue":"10","key":"2619_CR11","doi-asserted-by":"publisher","first-page":"3132","DOI":"10.1182\/blood.V97.10.3132","volume":"97","author":"CY Koh","year":"2001","unstructured":"Koh CY, et al. Augmentation of antitumor effects by NK cell inhibitory receptor blockade in vitro and in vivo. Blood. 2001;97(10):3132\u20137.","journal-title":"Blood"},{"issue":"4","key":"2619_CR12","doi-asserted-by":"publisher","first-page":"e008755","DOI":"10.1136\/jitc-2023-008755","volume":"13","author":"MM Cho","year":"2025","unstructured":"Cho MM, et al. CD155 blockade enhances allogeneic natural killer cell-mediated antitumor response against osteosarcoma. J Immunother Cancer. 2025;13(4):e008755.","journal-title":"J Immunother Cancer"},{"issue":"1","key":"2619_CR13","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1111\/j.1600-065X.2010.00900.x","volume":"236","author":"JC Sun","year":"2010","unstructured":"Sun JC, Beilke JN, Lanier LL. Immune memory redefined: characterizing the longevity of natural killer cells. Immunol Rev. 2010;236(1):83\u201394.","journal-title":"Immunol Rev"},{"issue":"23","key":"2619_CR14","doi-asserted-by":"publisher","first-page":"4317","DOI":"10.1016\/j.cell.2022.10.006","volume":"185","author":"F Baharom","year":"2022","unstructured":"Baharom F, et al. Systemic vaccination induces CD8(+) T cells and remodels the tumor microenvironment. Cell. 2022;185(23):4317\u201332. e15.","journal-title":"Cell"},{"issue":"4","key":"2619_CR15","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.ccell.2020.07.013","volume":"38","author":"V Leko","year":"2020","unstructured":"Leko V, Rosenberg SA. Identifying and targeting human tumor antigens for T cell-based immunotherapy of solid tumors. Cancer Cell. 2020;38(4):454\u201372.","journal-title":"Cancer Cell"},{"issue":"31","key":"2619_CR16","doi-asserted-by":"publisher","first-page":"2206683","DOI":"10.1002\/smll.202206683","volume":"19","author":"H Liu","year":"2023","unstructured":"Liu H, Xie Z, Zheng M. Carbon dots and tumor antigen conjugates as nanovaccines for elevated cancer immunotherapy. Small. 2023;19(31):2206683.","journal-title":"Small"},{"issue":"11","key":"2619_CR17","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1166\/jbn.2021.3178","volume":"17","author":"J Zhao","year":"2021","unstructured":"Zhao J, Du G, Sun X. Tumor antigen-based nanovaccines for cancer immunotherapy: a review. J Biomed Nanotechnol. 2021;17(11):2099\u2013113.","journal-title":"J Biomed Nanotechnol"},{"key":"2619_CR18","first-page":"491","volume":"22","author":"X Zhang","year":"2023","unstructured":"Zhang X, et al. Engineered tumor cell-derived vaccines against cancer: the art of combating poison with poison. Bioact Mater. 2023;22:491\u2013517.","journal-title":"Bioact Mater"},{"issue":"1","key":"2619_CR19","doi-asserted-by":"publisher","first-page":"3.22. 1","DOI":"10.1002\/0471143030.cb0322s30","volume":"30","author":"C Thery","year":"2006","unstructured":"Thery C, et al. Isolation and characterization of exosomes from cell culture supernatants and biological fluids. Curr Protoc Cell Biol. 2006;30(1):3.22. 1\u20133.22. 29.","journal-title":"Curr Protoc Cell Biol"},{"issue":"4","key":"2619_CR20","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1016\/j.cell.2020.07.009","volume":"182","author":"A Hoshino","year":"2020","unstructured":"Hoshino A, et al. Extracellular vesicle and particle biomarkers define multiple human cancers. Cell. 2020;182(4):1044\u201361.","journal-title":"Cell"},{"key":"2619_CR21","doi-asserted-by":"publisher","first-page":"4751","DOI":"10.2147\/IJN.S417422","volume":"18","author":"Z Zou","year":"2023","unstructured":"Zou Z, et al. Current knowledge and future perspectives of exosomes as nanocarriers in diagnosis and treatment of diseases. Int J Nanomed. 2023;18:4751\u201378.","journal-title":"Int J Nanomed"},{"issue":"12","key":"2619_CR22","doi-asserted-by":"publisher","first-page":"5238","DOI":"10.1158\/0008-5472.CAN-04-3804","volume":"65","author":"R Gastpar","year":"2005","unstructured":"Gastpar R, et al. Heat shock protein 70 surface-positive tumor exosomes stimulate migratory and cytolytic activity of natural killer cells. Cancer Res. 2005;65(12):5238\u201347.","journal-title":"Cancer Res"},{"issue":"11","key":"2619_CR23","doi-asserted-by":"publisher","first-page":"2655","DOI":"10.1111\/j.1582-4934.2009.00851.x","volume":"14","author":"Y Xie","year":"2010","unstructured":"Xie Y, et al. Membrane-bound HSP70-engineered myeloma cell-derived exosomes stimulate more efficient CD8(+) CTL- and NK-mediated antitumour immunity than exosomes released from heat-shocked tumour cells expressing cytoplasmic HSP70. J Cell Mol Med. 2010;14(11):2655\u201366.","journal-title":"J Cell Mol Med"},{"issue":"3","key":"2619_CR24","doi-asserted-by":"publisher","first-page":"e1279372","DOI":"10.1080\/2162402X.2017.1279372","volume":"6","author":"E Vulpis","year":"2017","unstructured":"Vulpis E, et al. Genotoxic stress modulates the release of exosomes from multiple myeloma cells capable of activating NK cell cytokine production: Role of HSP70\/TLR2\/NF-kB axis. Oncoimmunology. 2017;6(3):e1279372.","journal-title":"Oncoimmunology"},{"key":"2619_CR25","doi-asserted-by":"publisher","first-page":"114519","DOI":"10.1016\/j.intimp.2025.114519","volume":"155","author":"M Tarin","year":"2025","unstructured":"Tarin M, et al. Exosomal PD-L1 in non-small cell lung cancer: implications for immune evasion and resistance to immunotherapy. Int Immunopharmacol. 2025;155:114519.","journal-title":"Int Immunopharmacol"},{"issue":"5","key":"2619_CR26","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1007\/s12185-022-03436-3","volume":"117","author":"T Yamamoto","year":"2023","unstructured":"Yamamoto T, Yamamoto Y, Ochiya T. Extracellular vesicle-mediated immunoregulation in cancer. Int J Hematol. 2023;117(5):640\u20136.","journal-title":"Int J Hematol"},{"issue":"2","key":"2619_CR27","doi-asserted-by":"publisher","first-page":"e000873","DOI":"10.1136\/jitc-2020-000873","volume":"8","author":"JE Park","year":"2020","unstructured":"Park JE, et al. Anti-tumor effects of NK cells and anti-PD-L1 antibody with antibody-dependent cellular cytotoxicity in PD-L1-positive cancer cell lines. J Immunother Cancer. 2020;8(2):e000873.","journal-title":"J Immunother Cancer"},{"issue":"4","key":"2619_CR28","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25(4):402\u20138.","journal-title":"Methods"},{"issue":"8","key":"2619_CR29","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1089\/ast.2013.0981","volume":"13","author":"Q Li","year":"2013","unstructured":"Li Q, et al. Effects of simulated microgravity on primary human NK cells. Astrobiology. 2013;13(8):703\u201314.","journal-title":"Astrobiology"},{"issue":"2","key":"2619_CR30","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.yexcr.2017.12.005","volume":"363","author":"Q Li","year":"2018","unstructured":"Li Q, et al. Bifacial effects of engineering tumour cell-derived exosomes on human natural killer cells. Exp Cell Res. 2018;363(2):141\u201350.","journal-title":"Exp Cell Res"},{"issue":"8","key":"2619_CR31","first-page":"4109","volume":"46","author":"S Naito","year":"1986","unstructured":"Naito S, et al. Growth and metastasis of tumor cells isolated from a human renal cell carcinoma implanted into different organs of nude mice. Cancer Res. 1986;46(8):4109\u201315.","journal-title":"Cancer Res"},{"issue":"6","key":"2619_CR32","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1016\/j.celrep.2017.04.031","volume":"19","author":"A Garcia-Diaz","year":"2017","unstructured":"Garcia-Diaz A, et al. Interferon receptor signaling pathways regulating PD-L1 and PD-L2 expression. Cell Rep. 2017;19(6):1189\u2013201.","journal-title":"Cell Rep"},{"issue":"21","key":"2619_CR33","doi-asserted-by":"publisher","first-page":"9543","DOI":"10.1128\/MCB.25.21.9543-9553.2005","volume":"25","author":"RV Parry","year":"2005","unstructured":"Parry RV, et al. CTLA-4 and PD-1 receptors inhibit T-cell activation by distinct mechanisms. Mol Cell Biol. 2005;25(21):9543\u201353.","journal-title":"Mol Cell Biol"},{"issue":"6","key":"2619_CR34","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1038\/gene.2008.45","volume":"9","author":"A Awasthi","year":"2008","unstructured":"Awasthi A, et al. Deletion of PI3K-p85alpha gene impairs lineage commitment, terminal maturation, cytokine generation and cytotoxicity of NK cells. Genes Immun. 2008;9(6):522\u201335.","journal-title":"Genes Immun"},{"issue":"6","key":"2619_CR35","doi-asserted-by":"publisher","first-page":"e010822","DOI":"10.1136\/jitc-2024-010822","volume":"13","author":"X Wang","year":"2025","unstructured":"Wang X, et al. Co-expression of IL-15 and CCL21 strengthens CAR-NK cells to eliminate tumors in concert with T cells and equips them with PI3K\/AKT\/mTOR signal signature. J Immunother Cancer. 2025;13(6):e010822.","journal-title":"J Immunother Cancer"},{"key":"2619_CR36","doi-asserted-by":"publisher","first-page":"66","DOI":"10.3389\/fonc.2018.00066","volume":"8","author":"C Rajagopal","year":"2018","unstructured":"Rajagopal C, Harikumar KB. The origin and functions of exosomes in cancer. Front Oncol. 2018;8:66.","journal-title":"Front Oncol"},{"issue":"17","key":"2619_CR37","doi-asserted-by":"publisher","first-page":"e2107394119","DOI":"10.1073\/pnas.2107394119","volume":"119","author":"M Tkach","year":"2022","unstructured":"Tkach M, et al. Extracellular vesicles from triple negative breast cancer promote pro-inflammatory macrophages associated with better clinical outcome. Proc Natl Acad Sci U S A. 2022;119(17):e2107394119.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"2619_CR38","doi-asserted-by":"publisher","first-page":"2783","DOI":"10.1016\/j.apsb.2021.01.001","volume":"11","author":"J Liu","year":"2021","unstructured":"Liu J, et al. The biology, function, and applications of exosomes in cancer. Acta Pharm Sin B. 2021;11(9):2783\u201397.","journal-title":"Acta Pharm Sin B"},{"issue":"11","key":"2619_CR39","doi-asserted-by":"publisher","first-page":"2635","DOI":"10.1007\/s11095-021-03143-4","volume":"39","author":"MN Huda","year":"2022","unstructured":"Huda MN, Nurunnabi M. Potential application of exosomes in vaccine development and delivery. Pharm Res. 2022;39(11):2635\u201371.","journal-title":"Pharm Res"},{"key":"2619_CR40","doi-asserted-by":"publisher","first-page":"121306","DOI":"10.1016\/j.biomaterials.2021.121306","volume":"280","author":"W Zhou","year":"2022","unstructured":"Zhou W, et al. Exosomes derived from immunogenically dying tumor cells as a versatile tool for vaccination against pancreatic cancer. Biomaterials. 2022;280:121306.","journal-title":"Biomaterials"},{"issue":"19","key":"2619_CR41","doi-asserted-by":"publisher","first-page":"15874","DOI":"10.1074\/jbc.M112.340588","volume":"287","author":"LH Lv","year":"2012","unstructured":"Lv LH, et al. Anticancer drugs cause release of exosomes with heat shock proteins from human hepatocellular carcinoma cells that elicit effective natural killer cell antitumor responses in vitro. J Biol Chem. 2012;287(19):15874\u201385.","journal-title":"J Biol Chem"},{"issue":"3","key":"2619_CR42","doi-asserted-by":"publisher","first-page":"611","DOI":"10.3390\/ijms20030611","volume":"20","author":"E Vulpis","year":"2019","unstructured":"Vulpis E, et al. Cancer exosomes as conveyors of stress-induced molecules: new players in the modulation of NK cell response. Int J Mol Sci. 2019;20(3):611.","journal-title":"Int J Mol Sci"},{"key":"2619_CR43","doi-asserted-by":"publisher","first-page":"508","DOI":"10.3389\/fimmu.2013.00508","volume":"4","author":"C Cerboni","year":"2014","unstructured":"Cerboni C, et al. The DNA damage response: a common pathway in the regulation of NKG2D and DNAM-1 ligandexpression in normal, infected, and cancer cells. Front Immunol. 2014;4:508.","journal-title":"Front Immunol"},{"issue":"4","key":"2619_CR44","doi-asserted-by":"publisher","first-page":"633","DOI":"10.7150\/ijbs.38414","volume":"16","author":"C Wang","year":"2020","unstructured":"Wang C, et al. Tumor cell-associated exosomes robustly elicit anti-tumor immune responses through modulating dendritic cell vaccines in lung tumor. Int J Biol Sci. 2020;16(4):633.","journal-title":"Int J Biol Sci"},{"issue":"1","key":"2619_CR45","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s12943-022-01515-x","volume":"21","author":"L Huang","year":"2022","unstructured":"Huang L, et al. Engineered exosomes as an in situ DC-primed vaccine to boost antitumor immunity in breast cancer. Mol Cancer. 2022;21(1):45.","journal-title":"Mol Cancer"},{"issue":"11","key":"2619_CR46","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1038\/s41419-020-03140-2","volume":"11","author":"Q Gou","year":"2020","unstructured":"Gou Q, et al. PD-L1 degradation pathway and immunotherapy for cancer. Cell Death Dis. 2020;11(11):955.","journal-title":"Cell Death Dis"},{"issue":"10","key":"2619_CR47","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1158\/2159-8290.CD-18-1259","volume":"9","author":"W Dong","year":"2019","unstructured":"Dong W, et al. The mechanism of anti-PD-L1 antibody efficacy against PD-L1-negative tumors identifies NK cells expressing PD-L1 as a cytolytic effector. Cancer Discov. 2019;9(10):1422\u201337.","journal-title":"Cancer Discov"},{"key":"2619_CR48","doi-asserted-by":"publisher","first-page":"886931","DOI":"10.3389\/fimmu.2022.886931","volume":"13","author":"R Bai","year":"2022","unstructured":"Bai R, Cui J. Burgeoning exploration of the role of natural killer cells in anti-PD-1\/PD-L1 therapy. Front Immunol. 2022;13:886931.","journal-title":"Front Immunol"},{"issue":"5","key":"2619_CR49","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1038\/ni1332","volume":"7","author":"JG O'Leary","year":"2006","unstructured":"O'Leary JG, et al. T cell- and B cell-independent adaptive immunity mediated by natural killer cells. Nat Immunol. 2006;7(5):507\u201316.","journal-title":"Nat Immunol"},{"issue":"4","key":"2619_CR50","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1016\/j.immuni.2015.09.013","volume":"43","author":"TE O'Sullivan","year":"2015","unstructured":"O'Sullivan TE, Sun JC, Lanier LL. Natural Killer Cell Memory. Immunity. 2015;43(4):634\u201345.","journal-title":"Immunity"},{"issue":"2","key":"2619_CR51","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/nri.2015.9","volume":"16","author":"A Cerwenka","year":"2016","unstructured":"Cerwenka A, Lanier LL. Natural killer cell memory in infection, inflammation and cancer. Nat Rev Immunol. 2016;16(2):112\u201323.","journal-title":"Nat Rev Immunol"},{"issue":"3","key":"2619_CR52","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3390\/vaccines8030394","volume":"8","author":"C Forrest","year":"2020","unstructured":"Forrest C, et al. NK cell memory to cytomegalovirus: implications for vaccine development. Vaccines (Basel). 2020;8(3):394.","journal-title":"Vaccines (Basel)"},{"issue":"1","key":"2619_CR53","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1186\/s13287-021-02655-5","volume":"12","author":"M Tarannum","year":"2021","unstructured":"Tarannum M, Romee R. Cytokine-induced memory-like natural killer cells for cancer immunotherapy. Stem Cell Res Ther. 2021;12(1):592.","journal-title":"Stem Cell Res Ther"},{"key":"2619_CR54","doi-asserted-by":"publisher","first-page":"525","DOI":"10.3389\/fimmu.2017.00525","volume":"8","author":"DFG Malone","year":"2017","unstructured":"Malone DFG, et al. Cytomegalovirus-driven adaptive-like natural killer cell expansions are unaffected by concurrent chronic hepatitis virus infections. Front Immunol. 2017;8:525.","journal-title":"Front Immunol"},{"key":"2619_CR55","doi-asserted-by":"publisher","first-page":"2796","DOI":"10.3389\/fimmu.2018.02796","volume":"9","author":"JHW Pahl","year":"2018","unstructured":"Pahl JHW, Cerwenka A, Ni J, Memory-Like NK. Cells: remembering a previous activation by cytokines and NK cell receptors. Front Immunol. 2018;9:2796.","journal-title":"Front Immunol"},{"issue":"1","key":"2619_CR56","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.ccell.2024.11.011","volume":"43","author":"CT Kureshi","year":"2025","unstructured":"Kureshi CT, Dougan SK. Cytokines in cancer. Cancer Cell. 2025;43(1):15\u201335.","journal-title":"Cancer Cell"},{"issue":"4","key":"2619_CR57","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1038\/nri3806","volume":"15","author":"J Crouse","year":"2015","unstructured":"Crouse J, Kalinke U, Oxenius A. Regulation of antiviral T cell responses by type I interferons. Nat Rev Immunol. 2015;15(4):231\u201342.","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"2619_CR58","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/j.immuni.2019.03.025","volume":"50","author":"HM Lazear","year":"2019","unstructured":"Lazear HM, Schoggins JW, Diamond MS. Shared and distinct functions of type I and type III Interferons. Immunity. 2019;50(4):907\u201323.","journal-title":"Immunity"},{"issue":"1","key":"2619_CR59","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.1038\/s41467-021-22755-3","volume":"12","author":"Q Lin","year":"2021","unstructured":"Lin Q, et al. IFN-gamma-dependent NK cell activation is essential to metastasis suppression by engineered Salmonella. Nat Commun. 2021;12(1):2537.","journal-title":"Nat Commun"},{"key":"2619_CR60","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.3389\/fimmu.2020.02189","volume":"11","author":"K Meissl","year":"2020","unstructured":"Meissl K, et al. STAT1 Isoforms differentially regulate NK cell maturation and anti-tumor activity. Front Immunol. 2020;11:2189.","journal-title":"Front Immunol"},{"issue":"6","key":"2619_CR61","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/S1043-4666(03)00226-6","volume":"23","author":"S Liang","year":"2003","unstructured":"Liang S, et al. IFNalpha regulates NK cell cytotoxicity through STAT1 pathway. Cytokine. 2003;23(6):190\u20139.","journal-title":"Cytokine"},{"key":"2619_CR62","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.cyto.2018.03.033","volume":"118","author":"N Keating","year":"2019","unstructured":"Keating N, Nicholson SE. SOCS-mediated immunomodulation of natural killer cells. Cytokine. 2019;118:64\u201370.","journal-title":"Cytokine"},{"issue":"8","key":"2619_CR63","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.4049\/jimmunol.2300469","volume":"211","author":"T Chen","year":"2023","unstructured":"Chen T, et al. Expression of concern: chemokine-containing exosomes are released from heat-stressed tumor cells via lipid raft-dependent pathway and act as efficient tumor vaccine. J Immunol. 2023;211(8):1250.","journal-title":"J Immunol"},{"issue":"24","key":"2619_CR64","doi-asserted-by":"publisher","first-page":"126097","DOI":"10.1016\/j.vaccine.2024.06.064","volume":"42","author":"D Zhang","year":"2024","unstructured":"Zhang D, et al. A novel costimulatory molecule gene-modified leukemia cell-derived exosome enhances the anti-leukemia efficacy of DC vaccine in mouse models. Vaccine. 2024;42(24):126097.","journal-title":"Vaccine"},{"issue":"6","key":"2619_CR65","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s00432-006-0184-7","volume":"133","author":"Y Yang","year":"2007","unstructured":"Yang Y, et al. Increased induction of antitumor response by exosomes derived from interleukin-2 gene-modified tumor cells. J Cancer Res Clin Oncol. 2007;133(6):389\u201399.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"1","key":"2619_CR66","doi-asserted-by":"publisher","first-page":"125","DOI":"10.3892\/mmr.2013.1759","volume":"9","author":"J Wang","year":"2014","unstructured":"Wang J, et al. More efficient induction of antitumor T cell immunity by exosomes from CD40L gene-modified lung tumor cells. Mol Med Rep. 2014;9(1):125\u201331.","journal-title":"Mol Med Rep"},{"issue":"1","key":"2619_CR67","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/bjc.2017.389","volume":"118","author":"MQ Yang","year":"2018","unstructured":"Yang MQ, et al. Interferon regulatory factor 1 priming of tumour-derived exosomes enhances the antitumour immune response. Br J Cancer. 2018;118(1):62\u201371.","journal-title":"Br J Cancer"},{"issue":"5","key":"2619_CR68","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.7150\/thno.68864","volume":"12","author":"CH Lee","year":"2022","unstructured":"Lee CH, et al. Macitentan improves antitumor immune responses by inhibiting the secretion of tumor-derived extracellular vesicle PD-L1. Theranostics. 2022;12(5):1971.","journal-title":"Theranostics"},{"key":"2619_CR69","doi-asserted-by":"publisher","first-page":"123524","DOI":"10.1016\/j.biomaterials.2025.123524","volume":"324","author":"Y Fu","year":"2026","unstructured":"Fu Y, et al. Genetically modified bacterial vesicles with interferon-gamma and tumor antigen remodel anti-tumor cellular immunity by modulating dendritic cells. Biomaterials. 2026;324:123524.","journal-title":"Biomaterials"},{"issue":"8","key":"2619_CR70","doi-asserted-by":"publisher","first-page":"R435","DOI":"10.1016\/j.cub.2018.01.059","volume":"28","author":"J Meldolesi","year":"2018","unstructured":"Meldolesi J. Exosomes and Ectosomes in Intercellular Communication. Curr Biol. 2018;28(8):R435\u201344.","journal-title":"Curr Biol"},{"issue":"3","key":"2619_CR71","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41556-025-01621-0","volume":"27","author":"DK Jeppesen","year":"2025","unstructured":"Jeppesen DK, et al. Blebbisomes are large, organelle-rich extracellular vesicles with cell-like properties. Nat Cell Biol. 2025;27(3):1\u201311.","journal-title":"Nat Cell Biol"}],"container-title":["Cell Communication and Signaling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12964-025-02619-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-025-02619-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-025-02619-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T15:03:54Z","timestamp":1770044634000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12964-025-02619-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,3]]},"references-count":71,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2619"],"URL":"https:\/\/doi.org\/10.1186\/s12964-025-02619-9","relation":{},"ISSN":["1478-811X"],"issn-type":[{"value":"1478-811X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,3]]},"assertion":[{"value":"5 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"We confirmed that all methods involving the human blood, mouse and cells adhered with the relevant institutional, national, and international guidelines and legislation.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"74"}}